IMP3 Expression in Borderline Tumors of the Ovary
نویسندگان
چکیده
منابع مشابه
Borderline Epithelial Tumors of the Ovary
Borderline ovarian tumors (BOT) were first described in 1929 by Taylor, which, due to the characteristics of the tumor, called it “semi malignant” or “borderline” [1]; subsequently, this group of tumors of the ovary were classified in 1973 by the World Health Organization as “low malignant potential ovarian tumor” [2] and, finally, in 2003 WHO separates them from carcinomas and call them border...
متن کاملExpression of p16, p53, CD24, EpCAM and calretinin in serous borderline tumors of the ovary.
OBJECTIVE According to the widely accepted pathway, a serous borderline tumor becomes invasive either by progressing into a noninvasive micropapillary tumor or directly through microinvasion. Our objective was to investigate the role of serous borderline tumors and their accompanying extraovarian lesions in pathogenesis of serous ovarian cancer using immunohistochemistry as a tool. MATERIAL A...
متن کاملBorderline epithelial tumors of the ovary: Experience of 55 patients
The objective of the present study was to evaluate the clinicopathological features and the survival time estimates in patients treated for borderline ovarian tumors (BOTs). A retrospective review of all patients treated for BOTs at the University of Bari (Bari, Italy) between 1991 and 2011 was performed. Data were obtained from hospital records and gynecological oncology charts. A total of 55 ...
متن کاملBorderline tumors of the ovary: clinical course and prognostic factors.
BACKGROUND The prognosis in borderline tumors of the ovary (BOT) is generally favorable. However, some patients experience recurrence, and mortalities occur. There is a need to better characterize prognostic factors to be considered for individualized treatment planning. PATIENTS AND METHODS The data of 158 consecutive patients who underwent surgery for BOT at a tertiary referral center for g...
متن کاملBorderline tumors of the ovary: A clinicopathological study
OBJECTIVE To report experience with borderline ovarian tumors (BOTs) in a developing country like Pakistan with limited resources and weak database of health system. METHODS Patients with BOTs managed at Shaukat Khanum Cancer hospital, Lahore, Pakistan from 2004 to 2014 were included and reviewed retrospectively. Data was recorded on histopathological types, age, CA-125, stage of disease, tre...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Anticancer Research
سال: 2017
ISSN: 0250-7005,1791-7530
DOI: 10.21873/anticanres.11351